Cost-utility analysis in depression: The McSad utility measure for depression health states

被引:36
|
作者
Bennett, KJ
Torrance, GW
Boyle, MH
Guscott, R
机构
[1] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] McMaster Univ, Ctr Hlth Econ & Policy Anal, Hamilton, ON L8S 4L8, Canada
[4] McMaster Univ, Sch Business, Hamilton, ON L8S 4L8, Canada
关键词
D O I
10.1176/appi.ps.51.9.1171
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cost-utility analysis, used increasingly over the past decade to analyze costs and effects in treating physical diseases, has received little attention in psychiatry. This article briefly introduces the concepts and methods of utility measurement and illustrates it using depression as an example. The authors describe the McSad health state classification system for depression, a direct utility measure for depression, and report results of an application of McSad among 105 patients who had a recent history of depression. Utility measures express patient preferences for specific health states on a scale ranging from 0, representing death, to 1, representing perfect health. These scores provide the weights used to calculate the number of quality-adjusted Life-years gained by an intervention or set-vice. McSad allows a patient's depression health state to be classified according to level of functioning in six dimensions of depression and to be compared with other hypothetical depression health states in order to produce utility scores indicating the patient's relative preferences.
引用
收藏
页码:1171 / 1176
页数:6
相关论文
共 50 条
  • [31] Cost-utility analysis in schizophrenia
    Awad, AG
    Voruganti, LP
    JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 : 22 - 28
  • [32] Cost-utility analysis and otolaryngology
    Hamilton, D.
    Hulme, C.
    Flood, L.
    Powell, S.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2014, 128 (02): : 112 - 118
  • [33] Cost-utility analysis - Response
    Neumann, PJ
    Chapman, RH
    Stone, PW
    ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) : 626 - 626
  • [34] Cost-utility analysis of adjunct repetitive transcranial magnetic stimulation for treatment resistant bipolar depression
    Chatterton, Mary Lou
    Lee, Yong Yi
    Le, Long Khanh-Dao
    Nichols, Melanie
    Carter, Rob
    Berk, Michael
    Mihalopoulos, Cathrine
    JOURNAL OF AFFECTIVE DISORDERS, 2024, 356 : 639 - 646
  • [35] Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia
    Serrano-Blanco, A.
    Pinto-Meza, A.
    Suarez, D.
    Penarrubia, M. T.
    Haro, J. M.
    ACTA PSYCHIATRICA SCANDINAVICA, 2006, 114 : 39 - 47
  • [36] Cost-utility of screening for depression among asylum seekers: a modelling study in Germany
    Biddle, Louise
    Miners, Alec
    Bozorgmehr, Kayvan
    HEALTH POLICY, 2019, 123 (09) : 873 - 881
  • [37] Cost-utility of screening for depression amongst asylum seekers: a modelling study in Germany
    Bartelt, L.
    Bozorgmehr, K.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2018, 28 : 108 - 108
  • [38] Cost-Utility Analyses of Cognitive-Behavioural Therapy of Depression: A Systematic Review
    Brettschneider, Christian
    Djadran, Helei
    Haerter, Martin
    Loewe, Bernd
    Riedel-Heller, Steffi
    Koenig, Hans-Helmut
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 (01) : 6 - 21
  • [39] Cost-utility of public health nurse-delivered group cognitive behavioural therapy for postpartum depression
    Layton, Haley
    Huh, Kathryn
    Savoy, Calan D.
    Xie, Feng
    Van Lieshout, Ryan J.
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 379 : 673 - 679
  • [40] The use of health utility in cost-utility analysis: A systematic review in substance use disorders
    Tran, Anh Dam
    Zhan, Xin
    Vinzent, Annaelle
    Flood, Lorelie
    Bai, Tian
    Gallagher, Erinn
    Zaric, Gregory S.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2024, 133